MARIETTA, Ga., Aug. 8, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced an agreement with the plaintiff (the "Plaintiff") in the matter City of Hialeah Employees' Retirement System v. MiMedx Group, Inc. As has been previousl

FLINT, Mich., Aug. 8, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency,

WINNIPEG, Aug. 8, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter ended June 30, 2019.  Quarter Ended June 30, 2019 Highlights:

SAN ANTONIO, Aug. 8, 2019 /PRNewswire/ -- When Americans return to work and school after summer vacation, the fall allergy season will begin to impact many of the nearly 50 million allergy sufferers across the country1. According to the Asthma and Allergy Foundation of America, Americans lost more than 6 million work and school days in 2018, costing about

GERMANTOWN, Md., Aug. 8, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended June 30, 2019, and prov

OAKLAND, Calif., Aug. 8, 2019 /PRNewswire/ -- An effort to improve the scheduled cesarean section delivery experience found that changes to preoperative and postoperative processes can lead to reductions in opioid use without increased pain and with faster recovery, according to research from Kaiser Permanente published in the journal Obstetrics & Gynecology.

LOS ANGELES, Aug. 8, 2019 /PRNewswire/ -- "Speak Life," "Share Life," and "Take Flight," are some of the positive messages on a new colorful mural painted by South Los Angeles at-risk middle school and high school students and community artist Moses Ball.

SAN FRANCISCO, Aug. 8, 2019 /PRNewswire/ --  Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2019.Cash and investments in marketable securities at June 30, 2019 were $1.8 billion as compared to

SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage Precision Cancer Medicine™ company, developing drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced company highlights and financial results for the second quarter ended